My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:DMED)

0.1000 -0.0050 (-4.76%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,355,378
Open 0.1100
Bid (Size) 0.0900 (6,000)
Ask (Size) 0.1050 (146,000)
Prev. Close 0.1050
Today's Range 0.0900 - 0.1200
52wk Range 0.0050 - 0.1200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DiagnaMed Strengthens Leadership Team and Confirms Completion of Extensive Hydrogen Soil Sampling Program in Ontario's Temiscamingue Graben
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the... 
Via Newsfile
Topics Climate Change
DiagnaMed Congratulates QIMC on Quebec Drill Permit Approval and Announces Significant Progress on Ontario Clean Natural Hydrogen Soil Sampling Program
Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") proudly... 
Via Newsfile

Performance

YTD
+185.7%
+185.7%
1 Month
+42.9%
+42.9%
3 Month
+233.3%
+233.3%
6 Month
+300.0%
+300.0%
1 Year
+900.0%
+900.0%

More News

Read More
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Via Newsfile
DiagnaMed Announces Chief Financial Officer Transition
Via Newsfile
DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board
Via Newsfile
DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben
Via Newsfile
DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
From Revive Therapeutics Ltd.
Via GlobeNewswire
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
Via Newsfile
Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
From Revive Therapeutics Ltd.
Via GlobeNewswire
DiagnaMed Announces LIFE Offering of up to $510,000
Via Newsfile
Topics Artificial Intelligence
DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC
Via Newsfile
Topics Emissions
DiagnaMed Advances Hydrogen Energy Technology Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Resignation of Director and Grant of Stock Options
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Advancing the Medical Potential of Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Expands with Drug and Clinical Research AI Platform
From DiagnaMed Holdings Corp.
Via GlobeNewswire
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
From DiagnaMed Holdings Corp.
Via GlobeNewswire

Frequently Asked Questions

Is DMED publicly traded?
Yes, DMED is publicly traded.
What exchange does DMED trade on?
DMED trades on the Canadian Securities Exchange
What is the ticker symbol for DMED?
The ticker symbol for DMED is DMED on the Canadian Securities Exchange
What is the current price of DMED?
The current price of DMED is 0.1000
When was DMED last traded?
The last trade of DMED was at 10/01/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.